Brian Shoichet
Brian Shoichet
Professor of Pharmaceutical Chemistry, University of California, San Francisco
Verified email at cgl.ucsf.edu
Title
Cited by
Cited by
Year
ZINC− a free database of commercially available compounds for virtual screening
JJ Irwin, BK Shoichet
Journal of chemical information and modeling 45 (1), 177-182, 2005
36372005
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
DE Gordon, GM Jang, M Bouhaddou, J Xu, K Obernier, KM White, ...
Nature 583 (7816), 459-468, 2020
15932020
Predicting new molecular targets for known drugs
MJ Keiser, V Setola, JJ Irwin, C Laggner, AI Abbas, SJ Hufeisen, ...
Nature 462 (7270), 175-181, 2009
15002009
Relating protein pharmacology by ligand chemistry
MJ Keiser, BL Roth, BN Armbruster, P Ernsberger, JJ Irwin, BK Shoichet
Nature biotechnology 25 (2), 197-206, 2007
14282007
Benchmarking sets for molecular docking
N Huang, BK Shoichet, JJ Irwin
Journal of medicinal chemistry 49 (23), 6789-6801, 2006
13022006
Virtual screening of chemical libraries
BK Shoichet
Nature 432 (7019), 862-865, 2004
13012004
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
SL McGovern, E Caselli, N Grigorieff, BK Shoichet
Journal of medicinal chemistry 45 (8), 1712-1722, 2002
11812002
Automated docking with grid‐based energy evaluation
EC Meng, BK Shoichet, ID Kuntz
Journal of computational chemistry 13 (4), 505-524, 1992
11751992
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking
MM Mysinger, M Carchia, JJ Irwin, BK Shoichet
Journal of medicinal chemistry 55 (14), 6582-6594, 2012
10632012
A relationship between protein stability and protein function.
BK Shoichet, WA Baase, R Kuroki, BW Matthews
Proceedings of the National Academy of Sciences 92 (2), 452-456, 1995
7291995
Large-scale prediction and testing of drug activity on side-effect targets
E Lounkine, MJ Keiser, S Whitebread, D Mikhailov, J Hamon, JL Jenkins, ...
Nature 486 (7403), 361-367, 2012
7202012
Prediction of protein− ligand interactions. Docking and scoring: successes and gaps
AR Leach, BK Shoichet, CE Peishoff
Journal of medicinal chemistry 49 (20), 5851-5855, 2006
7082006
A specific mechanism of nonspecific inhibition
SL McGovern, BT Helfand, B Feng, BK Shoichet
Journal of medicinal chemistry 46 (20), 4265-4272, 2003
6472003
Structure-based discovery of opioid analgesics with reduced side effects
A Manglik, H Lin, DK Aryal, JD McCorvy, D Dengler, G Corder, A Levit, ...
Nature 537 (7619), 185-190, 2016
6062016
Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B
TN Doman, SL McGovern, BJ Witherbee, TP Kasten, R Kurumbail, ...
Journal of medicinal chemistry 45 (11), 2213-2221, 2002
5942002
Molecular docking using shape descriptors
BK Shoichet, ID Kuntz, DL Bodian
Journal of Computational Chemistry 13 (3), 380-397, 1992
5521992
The promise and peril of chemical probes
CH Arrowsmith, JE Audia, C Austin, J Baell, J Bennett, J Blagg, C Bountra, ...
Nature chemical biology 11 (8), 536-541, 2015
5482015
Identification and prediction of promiscuous aggregating inhibitors among known drugs
J Seidler, SL McGovern, TN Doman, BK Shoichet
Journal of medicinal chemistry 46 (21), 4477-4486, 2003
5262003
Lead discovery using molecular docking
BK Shoichet, SL McGovern, B Wei, JJ Irwin
Current opinion in chemical biology 6 (4), 439-446, 2002
5222002
Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs
X Wang, G Minasov, BK Shoichet
Journal of molecular biology 320 (1), 85-95, 2002
4622002
The system can't perform the operation now. Try again later.
Articles 1–20